5-POSITION MODIFIED PYRIMIDINES AND THEIR USE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150376223A1
SERIAL NO

14847150

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate derivatives thereof. The present disclosure also relates to methods of making and using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MADRYN HEALTH PARTNERS LPC/O MADRYN ASSET MANAGEMENT LP 140 E 45TH STREET 15TH FLOOR SUITE B NEW YORK NY 10017

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carter, Jeffrey D Longmont, US 12 123
Fowler, Catherine Boulder, US 6 48
Janjic, Nebojsa Boulder, US 100 2000
Rohloff, John Boulder, US 9 71

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation